← Leaderboards
Peter Poon-Hang Lee
Stanford University
$6,837,790
Attributed
$8,815,829
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $982.3K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,815,829 · 6
By mechanism
R01$5,373,063 · 3
U01$2,967,058 · 1
P30$296,968 · 1
K08$178,740 · 1
Top collaborators
- Russell Christian Rockne5 shared
- Andrei Rodin5 shared
Most similar at Stanford University
Same institution · by research overlap
- Steven E Artandi$26,596,623
- Gilbert Chu$3,230,030
- Craig S Levin$29,139,614
- Ken Sutha$499,488
- Todd Sulchek$3,054,760
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneTumorMalignant NeoplasmsNovel StrategiesImmune ResponseCellsResearch PersonnelCancer TherapyInsightCytokineImmune SystemFlow CytometryLeadMalignant Breast NeoplasmT-LymphocyteBaseHistologyHelper-Inducer T-LymphocyteImmunotherapyData AnalysesData SetCollaborationsBiologicalCd4 Positive T Lymphocytes
Grant awards (29)
Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer$183,872
U01 · FY2023 · CA · contact PI
Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer$612,300
U01 · FY2022 · CA · contact PI
Cancer Immunotherapeutics$60,976
P30 · FY2022 · CA · contact PI
Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer$921,294
U01 · FY2021 · CA · contact PI
Cancer Immunotherapeutics$60,976
P30 · FY2021 · CA · contact PI
Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer$624,796
U01 · FY2020 · CA · contact PI
Cancer Immunotherapeutics$68,118
P30 · FY2020 · CA · contact PI
Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer$624,796
U01 · FY2019 · CA · contact PI
Cancer Immunotherapeutics$59,314
P30 · FY2019 · CA · contact PI
Cancer Immunotherapeutics$45,501
P30 · FY2018 · CA · contact PI
Cancer Immunotherapeutics$2,083
P30 · FY2018 · CA · contact PI
Interplay Between Cancer and Immune Cells on Targeted Therapy$341,262
R01 · FY2012 · CA · contact PI
Interplay Between Cancer and Immune Cells on Targeted Therapy$450,198
R01 · FY2011 · CA · contact PI
Immune Profile Analysis of Tumor-Draining Lymph Nodes in Breast Cancer$252,440
R01 · FY2011 · CA · contact PI
Immune Profile Analysis of Tumor-Draining Lymph Nodes in Breast Cancer$116,079
R01 · FY2011 · CA · contact PI
Interplay Between Cancer and Immune Cells on Targeted Therapy$444,515
R01 · FY2010 · CA · contact PI
Immune Profile Analysis of Tumor-Draining Lymph Nodes in Breast Cancer$364,799
R01 · FY2010 · CA · contact PI
Interplay Between Cancer and Immune Cells on Targeted Therapy$437,707
R01 · FY2009 · CA · contact PI
Immune Profile Analysis of Tumor-Draining Lymph Nodes in Breast Cancer$358,017
R01 · FY2009 · CA · contact PI
Interplay Between Cancer and Immune Cells on Targeted Therapy$435,170
R01 · FY2008 · CA · contact PI
Immune Profile Analysis of Tumor-Draining Lymph Nodes in Breast Cancer$347,963
R01 · FY2008 · CA · contact PI
Immune Profile Analysis of Tumor-Draining Lymph Nodes in Breast Cancer$358,886
R01 · FY2007 · CA · contact PI
Characterization of Tumor Specific T Cells in Melanoma$303,175
R01 · FY2005 · CA
Characterization of Tumor Specific T Cells in Melanoma$301,936
R01 · FY2004 · CA
Characterization of Tumor Specific T Cells in Melanoma$300,732
R01 · FY2003 · CA
Characterization of Tumor Specific T Cells in Melanoma$299,564
R01 · FY2002 · CA
Characterization of Tumor Specific T Cells in Melanoma$260,620
R01 · FY2001 · CA
ENDOGENOUS T CELL RESPONSES TO MELANOMA$89,370
K08 · FY2001 · CA
ENDOGENOUS T CELL RESPONSES TO MELANOMA$89,370
K08 · FY2000 · CA